Frequently Asked Questions
The market is segmented based on , By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2029
.
The Europe Respiratory Diagnostics Market size was valued at USD 1.92 USD Billion in 2021.
The Europe Respiratory Diagnostics Market is projected to grow at a CAGR of 7.4% during the forecast period of 2022 to 2029.
The market report covers data from the U.S., Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
